Gilchrist v. Bristol-Myers Squibb Company, Inc. et al
Defendant: McKesson Corporation, AstraZeneca Pharmaceuticals LP and Bristol-Myers Squibb Company, Inc.
Executor: Kelvin L. Gilchrist
Case Number: 5:2020cv00281
Filed: July 1, 2020
Court: US District Court for the Eastern District of Kentucky
Presiding Judge: Karen K Caldwell
Nature of Suit: Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability
Cause of Action: 28 U.S.C. § 1332
Jury Demanded By: Plaintiff
Docket Report

This docket was last retrieved on August 19, 2020. A more recent docket listing may be available from PACER.

Date Filed Document Text
August 19, 2020 Opinion or Order Filing 13 MEMORANDUM OPINION & ORDER: 1) Plas Motion to Compel and for Sanctions (DE 479 ) is GRANTED IN PART as following: a) Redactions of date of death and treatment duration to Exhibits 11, 12, and 13 of Motion and Exhibit 3 to Reply where those dates are expressed as a number of days rather than a calendar date; b) Redactions for "nonresponsiveness" to Exhibit 14 that are part of email chain entitled "June 16, 2014 Email from Krisztina Debreczeni to Rachpal Malhotra, et al."; c) Exhibits 9 of Motion and Exhibits 6, 7, 8, 9, and 10 to Reply, to extent these are publicly available documents; 2) Plas Motion to Compel and for Sanctions (DE 479 ) is DENIED IN PART as following: a) Redactions of pharmocovigilance information not related to heart failure and/or increased risk of adverse cardiac events; b) Redaction of OneNote files due to "nonresponsiveness"; and c) The request for sanctions. Within 14 days either party may appeal this decision to Judge Caldwell pursuant 636(b)(1)(A) and FRCP 72(a). Signed by Magistrate Judge Matthew A. Stinnett on 8/19/2020. Associated Cases: 5:18-md-02809-KKC-MAS et al. (TDA) cc: COR
August 17, 2020 Filing 12 JOINT STATUS REPORT by AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, McKesson Corporation. Associated Cases: 5:18-md-02809-KKC-MAS et al.(Ullman, Emily)
July 23, 2020 Opinion or Order Filing 11 ORDER: The parties have filed various stipulations of dismissal into the record. In order that such stipulations be presented to the Court efficiently, the Court hereby ORDERS that, when electronically filing such stipulations, the parties SHALL SELECT the motion relief Proposed Agreed Order/Stipulation in CM-ECF. Signed by Judge Karen K. Caldwell on 7/23/2020.Associated Cases: 5:18-md-02809-KKC-MAS et al.(CBD)cc: COR
July 22, 2020 Filing 10 NOTICE by Carolyn Williams PLAINTIFFS NOTICE OF SERVICE OF GENERAL CAUSATION EXPERT REPORTS Associated Cases: 5:18-md-02809-KKC-MAS et al.(Clark, Timothy)
July 21, 2020 Opinion or Order Filing 9 ORDER: the telephonic status conference currently scheduled for July 22, 2020, the Court hereby ORDERS that the status conference is CANCELED. The Court further hereby ORDERS that a TELEPHONIC STATUS CONFERENCE is SCHEDULED for September 15, 2020 at 1:00 p.m. local time. Counsel shall access the call by (directives contained in this order.) Signed by Judge Karen K. Caldwell on 7/21/2020.Associated Cases: 5:18-md-02809-KKC-MAS et al.(CBD)cc: COR, Lex D
July 17, 2020 Opinion or Order Filing 8 CASE MANAGEMENT ORDER NO. 9: In their Joint Motion (DE 514 in 5:18-md-2809, et al) to Amend Case Management Order No. 8, the parties request extensions of the deadlines for expert discovery pertaining to general causation established by Case Management Order No. 8 (DE 474 in 5:18-md-2809, et al). The Court hereby ORDERS that the expert discovery deadlines are REVISED as follows: 1) Plaintiffs must serve expert reports relating to the issue of general causation by July 21, 2020; 2) Defendants must serve expert reports relating to the issue of general causation by August 14, 2020; 3) Plaintiffs must serve rebuttal expert reports by August 31, 2020; 4) Depositions of expert witnesses on the issue of general causation must be completed by October 2, 2020; 5) Any Daubert motions challenging expert witness testimony on the issue of general causation must be filed by October 23, 2020. Any responses to such motions must be filed by November 20, 2020. Any replies must be filed by December 8, 2020. 6) Hearings on any Daubert motions will take place the week of January 19, 2021. Signed by Judge Karen K. Caldwell on 7/17/2020. Associated Cases: 5:18-md-02809-KKC-MAS et al.(CBD)cc: COR
July 16, 2020 Opinion or Order Filing 7 ORDER: 1) Plaintiffs' Motion for Leave to Seal a Document at (DE 511 in 5:18-md-2809, et al) is GRANTED; 2) Defendants Motion for Leave to Seal a Document at (DE 516 in 5:18-md- 2809, et al)is GRANTED; and 3) Defendants Motion for Leave to File a Sur-reply [DE 515 in 5:18-md-2809, et al)] is GRANTED to the extent it addresses Exhibit 6 to Plaintiffs Reply Brief [DE 512 in 5:18-md- 2809, et al)].1 4) The Court grants the motions to seal without making any determination as to the underlying discovery dispute. 5) No further briefing or sur-replies related to DE 479 will be permitted. Signed by Magistrate Judge Matthew A. Stinnett on 7/15/2020. Associated Cases: 5:18-md-02809-KKC-MAS et al.(CBD)cc: COR
July 15, 2020 Filing 6 JOINT STATUS REPORT by AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, McKesson Corporation. Associated Cases: 5:18-md-02809-KKC-MAS et al.(Ullman, Emily)
July 10, 2020 Filing 5 MOTION for leave to Maintain Exhibits Under Seal Exhibits 3-10 re (513 in 5:18-md-02809-KKC-MAS) Sealed Document, by AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company (Attachments: #1 Proposed Order)Associated Cases: 5:18-md-02809-KKC-MAS et al.(Ullman, Emily) Modified text on 7/22/2020 (TDA).
July 3, 2020 Filing 4 MOTION for Leave by AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company to File Surreply to Plaintiffs' Motion to Compel Motions referred to Matthew A. Stinnett. (Attachments: #1 Proposed Order, #2 Exhibit A - Proposed Surreply)Associated Cases: 5:18-md-02809-KKC-MAS et al.(Ullman, Emily)
July 1, 2020 Filing 3 STANDING ORDER: 1. The Clerk is DIRECTED to ASSIGN all related matters to the Honorable Karen K. Caldwell on the Lexington docket. 2. All individual actions shall be consolidated with the MDL Master File No. 5:18-md-2809. 3. Actions shall be consolidated for purposes of discovery and other pre-trial matters. 4. A copy of this Order shall be filed in each appropriate case with a copy to all counsel. (JLM)cc: COR
July 1, 2020 Filing 1 COMPLAINT (NO PROCESS REQUESTED). ( Filing fee $400; receipt number 0643-4710951), filed by Kelvin L. Gilchrist. (Attachments: #1 Civil Cover Sheet)(JLM)
July 1, 2020 Conflict Check run. (JLM)
July 1, 2020 REMARK: Counsel is on notice that they shall refer to #www.kyed.uscourts.gov/518-md-02809-kkc for review of Orders, including but not limited to the Order Regarding Practice and Procedure Upon Transfer and Case Management Orders governing all cases in these MDL proceedings. If you are not registered as an ECF Filing User, please complete the ECF Registration Form and return it to the Clerk within twenty-one (21) days. cc: Order Regarding Practice & Procedure upon Transfer filed February 9, 2018 served via U.S. Mail to counsel not registered as ECF Filing Users. (CBD)

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the Kentucky Eastern District Court's Electronic Court Filings (ECF) System

Search for this case: Gilchrist v. Bristol-Myers Squibb Company, Inc. et al
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Executor: Kelvin L. Gilchrist
Represented By: Jennifer A. Moore
Represented By: Ashton Rose Smith
Represented By: Laraclay Drake Parker
Represented By: Timothy Michael Clark
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: McKesson Corporation
Represented By: Emily S. Ullman
Represented By: Phyllis Jones
Represented By: Paul W. Schmidt
Represented By: Carol Dan Browning
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: AstraZeneca Pharmaceuticals LP
Represented By: Emily S. Ullman
Represented By: Phyllis Jones
Represented By: Paul W. Schmidt
Represented By: Carol Dan Browning
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Bristol-Myers Squibb Company, Inc.
Represented By: Emily S. Ullman
Represented By: Phyllis Jones
Represented By: Paul W. Schmidt
Represented By: Carol Dan Browning
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?